The flow cytometry results revealed that neither CD4+ nor CD8+ VSTs initiated a response to SARS-CoV-2 in patients with ILD from 7 to 18 days PSO (Supplementary Figure S3). This evidence concerns the gene CD4 and interstitial lung disease.